Key | % Net Assets |
---|---|
Roche Holding AG | 5.6% |
BG GROUP | 4.6% |
EFG Eurobank Ergasias S.A. | 4.3% |
ASML Holding N.V. | 4.2% |
Other | 81.3% |
Name | % Net Assets |
---|---|
Roche Holding AG | 5.6% |
BG GROUP | 4.6% |
EFG Eurobank Ergasias S.A. | 4.3% |
ASML Holding N.V. | 4.2% |
Lanxess AG | 3.8% |
Key | % Net Assets |
---|---|
Financials | 16.70% |
Health | 15.90% |
Industrial | 15.30% |
Consumer Services | 13.20% |
Basic Materials | 12.80% |
Date | 03-May-2024 |
---|---|
NAV | 542.35p |
Currency | GBP |
Change | 3.29p |
% | 0.61% |
YTD change | 44.98p |
YTD % | 9.04% |
Fund Inception | 12/07/2004 |
---|---|
Fund Manager | Phil Cliff |
TER | 1.10 (30-Mar-2012) |
Minimum Investment | |
---|---|
Initial | £50000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.00% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.09 |
You are here: research